Côte d'Ivoire vs Ethiopia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Côte d'Ivoire
0.6%
in 2024
Ethiopia
0.6%
in 2024
Côte d'Ivoire rank
60th
Ethiopia rank
60th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Côte d'Ivoire
- Ethiopia
How they compare
Côte d'Ivoire currently reports 0.6% against 0.6% in Ethiopia, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 60th and Ethiopia ranks 60th of 246 countries.
Côte d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Ethiopia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 1.2% | 0.0% | Côte d'Ivoire |
| 2020s | 0.7% | 0.7% | 0.0% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Côte d'Ivoire or Ethiopia?
- Côte d'Ivoire, at 0.6% against 0.6% in Ethiopia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Côte d'Ivoire and Ethiopia?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Ethiopia?
- 10 years are reported by both, from 2015 to 2024.
- How do Côte d'Ivoire and Ethiopia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Côte d'Ivoire ranks 60th and Ethiopia ranks 60th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.